Mon, April 15, 2024
Fri, April 12, 2024
Thu, April 11, 2024

Serge Belanger Reiterated (ARQT) at Strong Buy and Held Target at $16 on, Apr 12th, 2024

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-16-on-apr-12th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Serge Belanger of Needham, Reiterated "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy and Held Target at $16 on, Apr 12th, 2024.

Serge has made no other calls on ARQT in the last 4 months.



There are 2 other peers that have a rating on ARQT. Out of the 2 peers that are also analyzing ARQT, 1 agrees with Serge's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jonathan Block of "Goldman Sachs" Maintained at Hold with Increased Target to $11 on, Wednesday, February 28th, 2024


This is the rating of the analyst that currently disagrees with Serge


  • Uy Ear of "Mizuho" Reiterated at Strong Buy with Increased Target to $17 on, Wednesday, February 28th, 2024